CVS Health raised its 2026 earnings and cash-flow outlook after second-quarter adjusted earnings rose 42.5% to $2.58 per share and revenues increased 7.3% to $106.10 billion. The company lifted its 2026 adjusted EPS guidance to $7.90-$8.10 from $7.30-$7.50, with consolidated revenues of at least $414 billion and adjusted operating income of $16.58-$16.92 billion. Expected cash flow from operations rose to at least $11.5 billion from at least $9.5 billion. The Aetna Health Care Benefits segment drove the improvement, with second-quarter adjusted operating income up 85.5% to $2.43 billion and its medical benefit ratio improving to 87.4% from 89.9%. CVS also raised that segment's 2026 adjusted operating income outlook to $5.03-$5.37 billion, more than $1 billion above prior guidance, while management cautioned that the medical benefit ratio is expected to rise materially through the second half and that 2027 pharmacy-services headwinds remain.
CVS Health CorpRaised 2026 EPS and cash-flow guidance after strong Q2 earnings.
Cigna Corp
UnitedHealth Group Incorporated